Sidney Chocron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sidney Chocron has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Camille Durst
Department of Cardiothoracic Surgery, Centre Hospitalier Universitaire de Besancon Ringgold Standard Institution, Besancon, France
6 shared publicationsDjamel Kaili
Department of Cardiothoracic Surgery, Centre Hospitalier Universitaire de Besancon Ringgold Standard Institution, Besancon, France
5 shared publications- Nicolas Meneveau
Department of Cardiology, University Hospital Besançon, Soins intégrés, nanomédecine, IA et ingénierie pour la santé, University of Franche-Comté, French Clinical Research Infrastructure Network, Investigation Network On Venous Thromboembolism, France (N. Meneveau, M.B.).
5 shared publications - Romain Chopard
Department of Cardiology, University Hospital Besançon, Besançon, France
4 shared publications Paul Luporsi
Department of Cardiology; University Hospital Jean Minjoz; Besançon France
3 shared publicationsAndrea Perrotti
Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France
2 shared publications
Latest Publications
- Open Access
- 24 August 2023
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 22 (1) , 1-8
Impact of early postoperative blood glucose variability on serum endocan level in cardiac surgery patients: a sub study of the ENDOLUNG observational study
Background: Early postoperative glycemic variability is associated with worse outcome after cardiac surgery, but the underlying mechanisms remain unknown. This study aimed to describe the relationship between postoperative glycemic variability and endothelial function, as assessed by serum endocan level in cardiac surgery patients. Methods: We performed a post hoc analysis of patients included in the single-center observational ENDOLUNG study. Adult patients who underwent planned isolated coronary artery bypass graft surgery were eligible. Postoperative glycemic variability was assessed by calculating the coefficient of variability (CV) of blood glucose measured within 24 (CV24) and 48 (CV48) hours after surgery. Serum endocan level was measured at 24 (Endocan24) and 48 (Endocan48) hours after surgery. Pearson’s correlation coefficient with 95% confidence interval (95% CI) was calculated between CV24 and Endocan24, and between CV48 and Endocan48. Results: Data from 177 patients were analyzed. Median CV24 and CV48 were 18% (range 7 to 39%) and 20% (range 7 to 35%) respectively. Neither CV48 nor CV24 were significantly correlated to Endocan48 and Endocan24 respectively (r (95% CI) = 0.150 (0.001 to 0.290; and r (95% CI) = 0.080 (-0.070 to 0.220), respectively). Conclusions: Early postoperative glycemic variability within 48 h after planned cardiac surgery does not appear to be correlated with postoperative serum endocan level. Clinical trial registration number: NCT02542423.
- 24 August 2023
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 22 (1) , 1-8
Open AccessImpact of early postoperative blood glucose variability on serum endocan level in cardiac surgery patients: a sub study of the ENDOLUNG observational study
Background: Early postoperative glycemic variability is associated with worse outcome after cardiac surgery, but the underlying mechanisms remain unknown. This study aimed to describe the relationship between postoperative glycemic variability and endothelial function, as assessed by serum endocan level in cardiac surgery patients. Methods: We performed a post hoc analysis of patients included in the single-center observational ENDOLUNG study. Adult patients who underwent planned isolated coronary artery bypass graft surgery were eligible. Postoperative glycemic variability was assessed by calculating the coefficient of variability (CV) of blood glucose measured within 24 (CV24) and 48 (CV48) hours after surgery. Serum endocan level was measured at 24 (Endocan24) and 48 (Endocan48) hours after surgery. Pearson’s correlation coefficient with 95% confidence interval (95% CI) was calculated between CV24 and Endocan24, and between CV48 and Endocan48. Results: Data from 177 patients were analyzed. Median CV24 and CV48 were 18% (range 7 to 39%) and 20% (range 7 to 35%) respectively. Neither CV48 nor CV24 were significantly correlated to Endocan48 and Endocan24 respectively (r (95% CI) = 0.150 (0.001 to 0.290; and r (95% CI) = 0.080 (-0.070 to 0.220), respectively). Conclusions: Early postoperative glycemic variability within 48 h after planned cardiac surgery does not appear to be correlated with postoperative serum endocan level. Clinical trial registration number: NCT02542423.
- Open Access
- 11 March 2019
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 18 (1) , 1-9
Impact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis
Background: Glycemic variability is associated with worse outcomes after cardiac surgery, but the prognosis value of early glycemic variability after transcatheter aortic valve implantation is not known. This study was therefore designed to analyze the prognosis significance of post-procedural glycemic variability within 30 days after transcatheter aortic valve implantation. Methods: A post hoc analysis of patients from our center included in the FRANCE and FRANCE-2 registries was conducted. Post-procedural glycemic variability was assessed by calculating the mean daily δ blood glucose during the first 2 days after transcatheter aortic valve implantation. Major complications within 30 days were death, stroke, myocardial infarction, acute heart failure, and life-threatening cardiac arrhythmias. Results: We analyzed 160 patients (age (median [interquartile] = 84 [80–88] years; diabetes mellitus (n) = 41 (26%) patients; logistic Euroscore = 20 [12–32]). The median value of mean daily δ blood glucose was 4.3 mmol l−1. The rate of major complications within 30 days after procedure among patients with the lowest quartile of glycemic variability was 12%, increasing from 12 to 26%, and 39% in the second, third, and fourth quartiles, respectively. In multivariate analysis, glycemic variability was independently associated with an increased risk of major complications within 30 days after the procedure (odds ratio [95% CI] = 1.83 [1.19–2.83]; p = 0.006). Conclusions: This study showed that post-procedural glycemic variability was associated with an increased risk of major complications within 30 days after transcatheter aortic valve implantation. Trial registration Clinical trial registration number https://www.clinicaltrials.gov/; identifier: NCT02726958; date: April 4th, 2016
- 11 March 2019
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 18 (1) , 1-9
Open AccessImpact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis
Background: Glycemic variability is associated with worse outcomes after cardiac surgery, but the prognosis value of early glycemic variability after transcatheter aortic valve implantation is not known. This study was therefore designed to analyze the prognosis significance of post-procedural glycemic variability within 30 days after transcatheter aortic valve implantation. Methods: A post hoc analysis of patients from our center included in the FRANCE and FRANCE-2 registries was conducted. Post-procedural glycemic variability was assessed by calculating the mean daily δ blood glucose during the first 2 days after transcatheter aortic valve implantation. Major complications within 30 days were death, stroke, myocardial infarction, acute heart failure, and life-threatening cardiac arrhythmias. Results: We analyzed 160 patients (age (median [interquartile] = 84 [80–88] years; diabetes mellitus (n) = 41 (26%) patients; logistic Euroscore = 20 [12–32]). The median value of mean daily δ blood glucose was 4.3 mmol l−1. The rate of major complications within 30 days after procedure among patients with the lowest quartile of glycemic variability was 12%, increasing from 12 to 26%, and 39% in the second, third, and fourth quartiles, respectively. In multivariate analysis, glycemic variability was independently associated with an increased risk of major complications within 30 days after the procedure (odds ratio [95% CI] = 1.83 [1.19–2.83]; p = 0.006). Conclusions: This study showed that post-procedural glycemic variability was associated with an increased risk of major complications within 30 days after transcatheter aortic valve implantation. Trial registration Clinical trial registration number https://www.clinicaltrials.gov/; identifier: NCT02726958; date: April 4th, 2016
- 1 July 2016
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 65 (04) , 265-271
Exclusive Bilateral Internal Thoracic Artery Grafts for Myocardial Revascularization Requiring Four Anastomoses or More: Outcomes from a Single Center Experience
Introduction Multivessel coronary artery bypass graft (CABG) with bilateral internal thoracic arteries (BITA) has only been uncommon and technically demanding. We describe our experience with BITA only CABGs requiring ≥ 4 anastomoses. Material and Methods The department's database was queried for patients undergoing isolated CABG with ≥ 4 anastomoses. The surgical technique included systematically a right internal thoracic artery (ITA) of left ITA Y graft. The multivariate model included variables with a p < 0.3 at univariate analysis. Results Between January 2006 and December 2009, 251 consecutive patients (71 ± 10 years) (on-pump: 130, off-pump: 121) had CABG with ≥ 4 anastomoses, representing 21% of total isolated CABGs for the same period; all patients received a totally arterial BITA only revascularization. Follow-up was 4.9 ± 1.6 years. Overall and cardiac cumulative survivals were 78 and 92%, respectively, at 5 years. The occurrence of any major postoperative complication was associated with overall and cardiac mortality (odds ratio [OR]: 3.6, 95% confidence interval [CI]: 1.3–9.9 and OR: 5.4, 95% CI: 1.3–21.9, respectively). Major sternal wound complication requiring surgical revision was not associated with impaired glucose control (n = 9; diabetics: 6/82, 7.3%; nondiabetics: 3/169, 1.8%, p = 0.06). Preoperative kidney failure was associated with incomplete revascularization (OR: 6.2; 95% CI: 1.2–33.5), that was unfailingly due to ungraftable right coronary artery targets. Discussion BITA only revascularization was a valuable and safe procedure, with favorable results in terms of morbidity and mortality at a 5 years' follow-up.
- 1 July 2016
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 65 (04) , 265-271
Exclusive Bilateral Internal Thoracic Artery Grafts for Myocardial Revascularization Requiring Four Anastomoses or More: Outcomes from a Single Center Experience
Introduction Multivessel coronary artery bypass graft (CABG) with bilateral internal thoracic arteries (BITA) has only been uncommon and technically demanding. We describe our experience with BITA only CABGs requiring ≥ 4 anastomoses. Material and Methods The department's database was queried for patients undergoing isolated CABG with ≥ 4 anastomoses. The surgical technique included systematically a right internal thoracic artery (ITA) of left ITA Y graft. The multivariate model included variables with a p < 0.3 at univariate analysis. Results Between January 2006 and December 2009, 251 consecutive patients (71 ± 10 years) (on-pump: 130, off-pump: 121) had CABG with ≥ 4 anastomoses, representing 21% of total isolated CABGs for the same period; all patients received a totally arterial BITA only revascularization. Follow-up was 4.9 ± 1.6 years. Overall and cardiac cumulative survivals were 78 and 92%, respectively, at 5 years. The occurrence of any major postoperative complication was associated with overall and cardiac mortality (odds ratio [OR]: 3.6, 95% confidence interval [CI]: 1.3–9.9 and OR: 5.4, 95% CI: 1.3–21.9, respectively). Major sternal wound complication requiring surgical revision was not associated with impaired glucose control (n = 9; diabetics: 6/82, 7.3%; nondiabetics: 3/169, 1.8%, p = 0.06). Preoperative kidney failure was associated with incomplete revascularization (OR: 6.2; 95% CI: 1.2–33.5), that was unfailingly due to ungraftable right coronary artery targets. Discussion BITA only revascularization was a valuable and safe procedure, with favorable results in terms of morbidity and mortality at a 5 years' follow-up.
- 1 March 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 99 (3) , 864-869
Neutrophil Gelatinase-Associated Lipocalin as Early Predictor of Acute Kidney Injury After Cardiac Surgery in Adults With Chronic Kidney Failure
- 1 March 2015
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 99 (3) , 864-869
Neutrophil Gelatinase-Associated Lipocalin as Early Predictor of Acute Kidney Injury After Cardiac Surgery in Adults With Chronic Kidney Failure
- 3 February 2015
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 30 (4) , 319-323
Early Detection of Asymptomatic Bypass Graft Abnormalities Using a Cardiac Troponin I Ratio Following Coronary Artery Bypass Surgery
BackgroundWe sought to identify the best cardiac Troponin I (cTnI) ratio to detect asymptomatic graft or anastomoses anomalies after myocardial revascularization. MethodsPatients with a rising cTnI profile, based on measurements at 6 and 12 hours (cTnI 12hours:6hours ratio >1) after the last anastomosis in off-pump surgery or after cardiopulmonary bypass in on-pump surgery, underwent a coronary angiogram, despite an uncomplicated postoperative course and absence of electrocardiogram changes. The optimal threshold value for the ratio was determined using a receiving operator characteristic (ROC) curve. ResultsFrom April 2005 to May 2011, among 1693 patients undergoing isolated coronary artery bypass graft (CABG), 29 (1.7%) had a cTnI ratio >1 and underwent postoperative angiography. Twenty abnormalities were observed in 16 patients (55%). In the anastomoses, there were four occlusions and four stenosis. In the grafts, there were 12 stenosis: two of the Y graft anastomosis, two dissections, five hematomas and three kinking. TIMI flow grade based on results of the Thrombolysis In Myocardial Infarction trial was 3 in six patients, 1 in five, and 0 in five. In the 16 patients with lesions, the cTnI ratio was 2.11.4 versus 1.4 +/- 0.3 in patients with no lesions (p=0.09). A ratio of 1.3 (p=0.003) was determined by ROC curve analysis as having the greatest discriminant capacity, with associated sensitivity of 87.5% and specificity of 62%. ConclusionA cTnI 12hours:6hours ratio >1.3 may be indicative of these abnormalities. Early identification of these anomalies may avoid adverse outcomes. doi: 10.1111/jocs.12517 (J Card Surg 2015;30:319-323)
- 3 February 2015
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 30 (4) , 319-323
Early Detection of Asymptomatic Bypass Graft Abnormalities Using a Cardiac Troponin I Ratio Following Coronary Artery Bypass Surgery
BackgroundWe sought to identify the best cardiac Troponin I (cTnI) ratio to detect asymptomatic graft or anastomoses anomalies after myocardial revascularization. MethodsPatients with a rising cTnI profile, based on measurements at 6 and 12 hours (cTnI 12hours:6hours ratio >1) after the last anastomosis in off-pump surgery or after cardiopulmonary bypass in on-pump surgery, underwent a coronary angiogram, despite an uncomplicated postoperative course and absence of electrocardiogram changes. The optimal threshold value for the ratio was determined using a receiving operator characteristic (ROC) curve. ResultsFrom April 2005 to May 2011, among 1693 patients undergoing isolated coronary artery bypass graft (CABG), 29 (1.7%) had a cTnI ratio >1 and underwent postoperative angiography. Twenty abnormalities were observed in 16 patients (55%). In the anastomoses, there were four occlusions and four stenosis. In the grafts, there were 12 stenosis: two of the Y graft anastomosis, two dissections, five hematomas and three kinking. TIMI flow grade based on results of the Thrombolysis In Myocardial Infarction trial was 3 in six patients, 1 in five, and 0 in five. In the 16 patients with lesions, the cTnI ratio was 2.11.4 versus 1.4 +/- 0.3 in patients with no lesions (p=0.09). A ratio of 1.3 (p=0.003) was determined by ROC curve analysis as having the greatest discriminant capacity, with associated sensitivity of 87.5% and specificity of 62%. ConclusionA cTnI 12hours:6hours ratio >1.3 may be indicative of these abnormalities. Early identification of these anomalies may avoid adverse outcomes. doi: 10.1111/jocs.12517 (J Card Surg 2015;30:319-323)
- 1 May 2014
- Vol. 23 (3) , 364-9
Six-year outcomes after non-resective mitral valve repair with artificial chordae using removable clips.
The results were evaluated of a non-resective technique for mitral valve repair with artificial chordae implantation that allows modification of the length of the chordae as many times as necessary, and avoids inadvertent alteration of chordal length during fixation by using removable clips. After having determined the length of the artificial chordae, a removable clip was tied on the two thread ends to prevent sliding when performing the competence test. The length of the artificial chordae could be modified by opening the clip and closing it elsewhere along the chordae length. When the competence test was satisfactory, the threads were knotted on the clips. Long-term follow up was completed between January and May 2012, by echocardiography plus consultation with a cardiologist at the authors' institution. A total of 47 patients underwent repair with this technique. Follow up was complete at a median of 6.0 years. There were no in-hospital deaths, but four deaths occurred during the follow up period (8.5%). The survival rate at six years was 91.5 +/- 2.1%. One patient (2.1%) had recurrent mitral regurgitation (MR) and required reoperation within two years after the initial surgery. The event-free survival rate, defined as survival free from death, reoperation or cardiovascular adverse events, was 87.2 +/- 5.2% at six years. At the time of follow up, echocardiography identified a fully competent valve or minimal MR in 45 patients (96%), mild MR in one patient (2.1%), and significant MR in one patient (2.1%). A satisfactory six-year outcome is reported for this method, whereby removable clips were used to determine the correct length of the artificial chordae, and for accurate tying of the knots.
- 1 May 2014
- Vol. 23 (3) , 364-9
Six-year outcomes after non-resective mitral valve repair with artificial chordae using removable clips.
The results were evaluated of a non-resective technique for mitral valve repair with artificial chordae implantation that allows modification of the length of the chordae as many times as necessary, and avoids inadvertent alteration of chordal length during fixation by using removable clips. After having determined the length of the artificial chordae, a removable clip was tied on the two thread ends to prevent sliding when performing the competence test. The length of the artificial chordae could be modified by opening the clip and closing it elsewhere along the chordae length. When the competence test was satisfactory, the threads were knotted on the clips. Long-term follow up was completed between January and May 2012, by echocardiography plus consultation with a cardiologist at the authors' institution. A total of 47 patients underwent repair with this technique. Follow up was complete at a median of 6.0 years. There were no in-hospital deaths, but four deaths occurred during the follow up period (8.5%). The survival rate at six years was 91.5 +/- 2.1%. One patient (2.1%) had recurrent mitral regurgitation (MR) and required reoperation within two years after the initial surgery. The event-free survival rate, defined as survival free from death, reoperation or cardiovascular adverse events, was 87.2 +/- 5.2% at six years. At the time of follow up, echocardiography identified a fully competent valve or minimal MR in 45 patients (96%), mild MR in one patient (2.1%), and significant MR in one patient (2.1%). A satisfactory six-year outcome is reported for this method, whereby removable clips were used to determine the correct length of the artificial chordae, and for accurate tying of the knots.
- 1 May 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 95 (5) , 1609-1618
Antidepressant Therapy in Patients Undergoing Coronary Artery Bypass Grafting: The MOTIV-CABG Trial
- 1 May 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 95 (5) , 1609-1618
Antidepressant Therapy in Patients Undergoing Coronary Artery Bypass Grafting: The MOTIV-CABG Trial
- Open Access
- 21 March 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (1) , 187-189
Left ventricular venting through the right subclavian artery access during peripheral extracorporeal life support
The use of peripheral extracorporeal life support during refractory cardiac arrest sometimes exposes the patient to left ventricular dilatation requiring venting. We report here a simple technique for LV venting by a cannula inserted through right subclavian artery and positioned in the left ventricle.
- 21 March 2013
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 17 (1) , 187-189
Open AccessLeft ventricular venting through the right subclavian artery access during peripheral extracorporeal life support
The use of peripheral extracorporeal life support during refractory cardiac arrest sometimes exposes the patient to left ventricular dilatation requiring venting. We report here a simple technique for LV venting by a cannula inserted through right subclavian artery and positioned in the left ventricle.
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 57
181 Evaluation of the radiation dose received by the medical team during transcatheter aortic valve implantation
- 1 January 2012
- Published by Elsevier in Archives of Cardiovascular Diseases Supplements
- Vol. 4 (1) , 57
181 Evaluation of the radiation dose received by the medical team during transcatheter aortic valve implantation